|
1
|
Safe handling of nanotechnology.
|
Nature
|
2006
|
7.25
|
|
2
|
Translocation of inhaled ultrafine manganese oxide particles to the central nervous system.
|
Environ Health Perspect
|
2006
|
3.16
|
|
3
|
Ultrafine particle deposition in humans during rest and exercise.
|
Inhal Toxicol
|
2003
|
2.06
|
|
4
|
Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs.
|
Inhal Toxicol
|
2009
|
1.78
|
|
5
|
Ultrafine particles in the urban air: to the respiratory tract--and beyond?
|
Environ Health Perspect
|
2002
|
1.76
|
|
6
|
The influence of protein adsorption on nanoparticle association with cultured endothelial cells.
|
Biomaterials
|
2008
|
1.68
|
|
7
|
Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium.
|
Environ Health Perspect
|
2007
|
1.65
|
|
8
|
Meeting report: hazard assessment for nanoparticles--report from an interdisciplinary workshop.
|
Environ Health Perspect
|
2007
|
1.64
|
|
9
|
Does Nanoparticle Activity Depend upon Size and Crystal Phase?
|
Nanotoxicology
|
2008
|
1.62
|
|
10
|
Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics.
|
J Toxicol Environ Health A
|
2010
|
1.61
|
|
11
|
Interlaboratory evaluation of rodent pulmonary responses to engineered nanomaterials: the NIEHS Nano GO Consortium.
|
Environ Health Perspect
|
2013
|
1.52
|
|
12
|
Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future.
|
ACS Nano
|
2010
|
1.49
|
|
13
|
Pulmonary function, diffusing capacity, and inflammation in healthy and asthmatic subjects exposed to ultrafine particles.
|
Inhal Toxicol
|
2004
|
1.45
|
|
14
|
Inhalation of ultrafine particles alters blood leukocyte expression of adhesion molecules in humans.
|
Environ Health Perspect
|
2006
|
1.44
|
|
15
|
Ultrafine particle deposition in subjects with asthma.
|
Environ Health Perspect
|
2004
|
1.40
|
|
16
|
Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology.
|
Toxicol Sci
|
2005
|
1.30
|
|
17
|
The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP).
|
Toxicol Sci
|
2005
|
1.29
|
|
18
|
Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma.
|
Res Rep Health Eff Inst
|
2004
|
1.25
|
|
19
|
Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation.
|
Part Fibre Toxicol
|
2014
|
1.24
|
|
20
|
Translocation and effects of ultrafine particles outside of the lung.
|
Clin Occup Environ Med
|
2006
|
1.20
|
|
21
|
Changes in deceleration capacity of heart rate and heart rate variability induced by ambient air pollution in individuals with coronary artery disease.
|
Part Fibre Toxicol
|
2010
|
1.16
|
|
22
|
Continued controversy on chrysotile biopersistence.
|
Int J Occup Environ Health
|
2011
|
1.12
|
|
23
|
Concepts of nanoparticle dose metric and response metric.
|
Environ Health Perspect
|
2007
|
1.12
|
|
24
|
The origin, fate, and health effects of combustion by-products: a research framework.
|
Environ Health Perspect
|
2002
|
1.10
|
|
25
|
Nanotoxicology: in vitro-in vivo dosimetry.
|
Environ Health Perspect
|
2012
|
1.09
|
|
26
|
Systemic effects of inhaled ultrafine particles in two compromised, aged rat strains.
|
Inhal Toxicol
|
2004
|
1.04
|
|
27
|
Recirculating air filtration significantly reduces exposure to airborne nanoparticles.
|
Environ Health Perspect
|
2008
|
1.03
|
|
28
|
Activation of pulmonary dendritic cells and Th2-type inflammatory responses on instillation of engineered, environmental diesel emission source or ambient air pollutant particles in vivo.
|
J Innate Immun
|
2010
|
1.03
|
|
29
|
Validation of an LDH assay for assessing nanoparticle toxicity.
|
Toxicology
|
2011
|
1.03
|
|
30
|
ECG parameters and exposure to carbon ultrafine particles in young healthy subjects.
|
Inhal Toxicol
|
2009
|
1.02
|
|
31
|
Induction of chemokines by low-dose intratracheal silica is reduced in TNFR I (p55) null mice.
|
Toxicol Sci
|
2003
|
1.01
|
|
32
|
A nanoparticle dispersion method for in vitro and in vivo nanotoxicity study.
|
Nanotoxicology
|
2010
|
1.00
|
|
33
|
On-road exposure to highway aerosols. 2. Exposures of aged, compromised rats.
|
Inhal Toxicol
|
2004
|
0.98
|
|
34
|
Early postnatal exposure to ultrafine particulate matter air pollution: persistent ventriculomegaly, neurochemical disruption, and glial activation preferentially in male mice.
|
Environ Health Perspect
|
2014
|
0.97
|
|
35
|
Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: a human inhalation study.
|
Am J Respir Crit Care Med
|
2005
|
0.97
|
|
36
|
Nanoparticle (NP) uptake by type I alveolar epithelial cells and their oxidant stress response.
|
Nanotoxicology
|
2009
|
0.92
|
|
37
|
Developmental exposure to concentrated ambient particles and preference for immediate reward in mice.
|
Environ Health Perspect
|
2012
|
0.92
|
|
38
|
Application of an informatics-based decision-making framework and process to the assessment of radiation safety in nanotechnology.
|
Health Phys
|
2015
|
0.91
|
|
39
|
Short-term effects of air pollution: a panel study of blood markers in patients with chronic pulmonary disease.
|
Part Fibre Toxicol
|
2009
|
0.90
|
|
40
|
Effects of on-road highway aerosol exposures on autonomic responses in aged, spontaneously hypertensive rats.
|
Inhal Toxicol
|
2007
|
0.90
|
|
41
|
Extraction and quantification of carbon nanotubes in biological matrices with application to rat lung tissue.
|
ACS Nano
|
2013
|
0.89
|
|
42
|
Time course of lung retention and toxicity of inhaled particles: short-term exposure to nano-Ceria.
|
Arch Toxicol
|
2014
|
0.88
|
|
43
|
Assessing the relevance of in vitro studies in nanotoxicology by examining correlations between in vitro and in vivo data.
|
Toxicology
|
2012
|
0.86
|
|
44
|
Impact of ambient air pollution on the differential white blood cell count in patients with chronic pulmonary disease.
|
Inhal Toxicol
|
2010
|
0.86
|
|
45
|
Endotoxin potentiates ozone-induced pulmonary chemokine and inflammatory responses.
|
Exp Lung Res
|
2002
|
0.86
|
|
46
|
Formation of PAH-DNA adducts after in vivo and vitro exposure of rats and lung cells to different commercial carbon blacks.
|
Toxicol Appl Pharmacol
|
2005
|
0.85
|
|
47
|
Incorporation of particle size differences between animal studies and human workplace aerosols for deriving exposure limit values.
|
Regul Toxicol Pharmacol
|
2010
|
0.85
|
|
48
|
Derivation of PM10 size-selected human equivalent concentrations of inhaled nickel based on cancer and non-cancer effects on the respiratory tract.
|
Inhal Toxicol
|
2014
|
0.77
|
|
49
|
In vitro dosing of cells with poorly soluble particles.
|
Toxicol Sci
|
2006
|
0.76
|
|
50
|
Quantitative risk analyses for RCF: survey and synthesis.
|
Regul Toxicol Pharmacol
|
2003
|
0.76
|
|
51
|
Reducing exposure to airborne particles: a novel strategy to improve cardiovascular health.
|
Am J Respir Crit Care Med
|
2008
|
0.75
|
|
52
|
Report: Combustion Byproducts and Their Health Effects: Summary of the 10th International Congress.
|
Environ Eng Sci
|
2008
|
0.75
|
|
53
|
[Toxicity of nano silica particles on rat type I-like alveolar epithelial cells].
|
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi
|
2009
|
0.75
|